Fill/finish adjuvant (AS03): multi-dose vials

Active Awarded Last action

Contract number
75A50126F61021
Awardee
Awarding agency
Obligated
$438,000

Award facts

Contract value 100% obligated
$438,000.00 Current and potential, with all options
Completion date 15% complete
Current and potential, with all options
Contracting staff
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27701, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Office of the Assistant Secretary for Preparedness and Response issued a $438,000 delivery order to Glaxosmithkline, LLC on September 1, 2026, for fill-finish adjuvant (AS03) in multi-dose vials, with an ultimate completion date of August 31, 2027.

Place of performance is Durham, NC. The order is priced on a firm fixed-price basis. No set-aside applies to this delivery order.

Quick answers

Who was awarded contract 75A50126F61021?

75A50126F61021 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 1, 2026.

How much is contract 75A50126F61021 worth?

The government has obligated $438,000 on 75A50126F61021.

Is contract 75A50126F61021 an order under another contract?

Yes. 75A50126F61021 is a delivery order under 75A50122D00002, an indefinite delivery contract.

Was contract 75A50126F61021 competed?

The extent of competition for 75A50126F61021 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award